Pre-Descemet corneal dystrophy (PDCD) is characterised by focal, fine, polymorphic grey opacities confined to the deep stroma immediately anterior to Descemet membrane. It involves the posterior stroma and nothing else, is bilateral, usually appears after the age of 30, and does not affect vision. Its status as a dystrophy is contested, and this entry curates the dispute rather than resolving it. The IC3D classification assigns PDCD to category 4, its lowest evidence tier, and states plainly that isolated PDCD is neither a well-defined entity nor clearly hereditary or degenerative. No gene, locus or MIM number is assigned. What ultrastructure exists points toward degeneration rather than storage of a genetically determined product: transmission electron microscopy shows membrane-bound intracellular vacuoles holding electron-dense material suggestive of secondary lysosomes, together with inclusions of a lipofuscin-like lipoprotein, and no extracellular deposits at all. That last detail is what most sharply separates PDCD from the classical stromal dystrophies it sits beside in the ontology, which are defined by abnormal material accumulating in the extracellular matrix and progressively opacifying the cornea. Against a purely degenerative reading, PDCD has been described in families over two to four generations, and some forms progress. Deep corneal deposits closely resembling PDCD are also frequently seen in X-linked ichthyosis, where they appear in the first decade and where every genetically characterised family carries a point mutation, partial deletion or complete deletion of STS at Xp22.31. Much of the ophthalmological literature labels those cases PDCD. IC3D explicitly declines to, on the ground that XLI is a systemic disease with corneal manifestations and therefore not a corneal dystrophy. Both arms are curated here, because MONDO:0017392 is the concept the clinical literature uses for both and because the two are told apart by skin examination, age of onset and STS analysis rather than by the corneal appearance - but the disagreement is recorded explicitly rather than smoothed over.
Ask a research question about Pre-Descemet Corneal Dystrophy. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from Pre-Descemet Corneal Dystrophy:
name: Pre-Descemet Corneal Dystrophy
creation_date: "2026-08-25T00:00:00Z"
description: >-
Pre-Descemet corneal dystrophy (PDCD) is characterised by focal, fine,
polymorphic grey opacities confined to the deep stroma immediately anterior to
Descemet membrane. It involves the posterior stroma and nothing else, is
bilateral, usually appears after the age of 30, and does not affect vision.
Its status as a dystrophy is contested, and this entry curates the dispute
rather than resolving it. The IC3D classification assigns PDCD to category 4,
its lowest evidence tier, and states plainly that isolated PDCD is neither a
well-defined entity nor clearly hereditary or degenerative. No gene, locus or
MIM number is assigned. What ultrastructure exists points toward degeneration
rather than storage of a genetically determined product: transmission electron
microscopy shows membrane-bound intracellular vacuoles holding electron-dense
material suggestive of secondary lysosomes, together with inclusions of a
lipofuscin-like lipoprotein, and no extracellular deposits at all. That last
detail is what most sharply separates PDCD from the classical stromal
dystrophies it sits beside in the ontology, which are defined by abnormal
material accumulating in the extracellular matrix and progressively opacifying
the cornea. Against a purely degenerative reading, PDCD has been described in
families over two to four generations, and some forms progress.
Deep corneal deposits closely resembling PDCD are also frequently seen in
X-linked ichthyosis, where they appear in the first decade and where every
genetically characterised family carries a point mutation, partial deletion or
complete deletion of STS at Xp22.31. Much of the ophthalmological literature
labels those cases PDCD. IC3D explicitly declines to, on the ground that XLI is
a systemic disease with corneal manifestations and therefore not a corneal
dystrophy. Both arms are curated here, because MONDO:0017392 is the concept the
clinical literature uses for both and because the two are told apart by skin
examination, age of onset and STS analysis rather than by the corneal
appearance - but the disagreement is recorded explicitly rather than smoothed
over.
category: Genetic
parents:
- Stromal Corneal Dystrophy
- Corneal Dystrophy
- Ophthalmological Disease
synonyms:
- PDCD
- pre-Descemet corneal dystrophy
- pre-Descemet's membrane corneal dystrophy
- deep filiform dystrophy
- deep punctiform dystrophy
disease_term:
preferred_term: pre-descemet corneal dystrophy
term:
id: MONDO:0017392
label: pre-descemet corneal dystrophy
mappings:
mondo_mappings:
- term:
id: MONDO:0017392
label: pre-descemet corneal dystrophy
mapping_predicate: skos:exactMatch
mapping_source: MONDO
classifications:
harrisons_chapter:
- classification_value: GENETICS_ENVIRONMENT_DISEASE
evidence:
- reference: PMID:37287641
reference_title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Pre-Descemet corneal dystrophy (PDCD) with X-linked ichthyosis (XLI) is
associated with mutations in or deletions of the steroid sulfatase gene
(STS).
explanation: >-
Establishes a defined single-gene lesion behind the best-characterised
arm of this entity.
- classification_value: DERMATOLOGY
evidence:
- reference: PMID:37287641
reference_title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Cutaneous examination demonstrated dry, coarse, scaly ichthyotic changes
characteristic of XLI in all individuals.
explanation: >-
The corneal finding in this arm is one manifestation of a systemic
keratinisation disorder, so the entity is also a dermatological one.
references:
- reference: PMID:37287641
title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
- reference: PMID:32482962
title: "Multimodal Imaging of Pre-Descemet Corneal Dystrophy Associated With X-Linked Ichthyosis and Deletion of the STS Gene."
- reference: PMID:28302098
title: "In vivo confocal microscopy of pre-Descemet corneal dystrophy associated with X-linked ichthyosis: a case report."
- reference: PMID:23807007
title: "Pre-Descemet corneal dystrophy and X-linked ichthyosis associated with deletion of Xp22.31 containing the STS gene."
- reference: PMID:38359414
title: "IC3D Classification of Corneal Dystrophies-Edition 3."
- reference: PMID:39086014
title: "Revisiting X-linked congenital ichthyosis."
- reference: PMID:31298040
title: "Multimodal imaging of pre-Descemet corneal dystrophy."
- reference: PMID:35346188
title: "Multimodal ocular imaging of known and novel corneal stromal disorders in dogs."
has_subtypes:
- name: Isolated PDCD
display_name: Isolated PDCD (IC3D category 4)
description: >-
PDCD occurring without ichthyosis and without an identified gene - the
entity MONDO and Orphanet actually define, and the one IC3D rates category 4.
IC3D assigns it no MIM number, no locus and no gene, and describes it as
neither well defined nor clearly hereditary or degenerative. The
countervailing observation is that it has been reported in families across
two to four generations, so a purely degenerative reading is not settled
either. Onset is usually after age 30, which distinguishes it from the
XLI-associated deposits of the other subtype.
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Isolated pre-Descemet corneal dystrophy (PDCD) is neither a well-defined
entity nor is it clearly a hereditary or degenerative disorder (known as
cornea farinata, "flour-like cornea").
explanation: >-
The classifying committee's own statement of the entity's uncertain status.
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Although no definite pattern of inheritance is established, it has been
described in families over 2 to 4 generations.
explanation: >-
Records the familial clustering that argues against reading isolated PDCD
as purely degenerative, while noting no inheritance pattern is established.
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Usually after age 30 years; although PPPCD has been found in children as
young as age 3 years.
explanation: >-
Gives the age of onset of this subtype, which is one of the features that
separates it from the XLI-associated deposits.
- name: XLI-Associated Deep Corneal Deposits
display_name: Deep corneal deposits of X-linked ichthyosis (STS)
description: >-
The genetically characterised arm, and the contested one. Affected men have
bilateral punctate posterior stromal opacities anterior to Descemet membrane
together with the dry, coarse, scaly skin of X-linked ichthyosis, and STS
analysis shows a point mutation, a partial deletion of the coding exons, or
a complete deletion of the locus at Xp22.31. That three different classes of
lesion produce an indistinguishable corneal phenotype is itself the argument
that they all act through loss of steroid sulfatase function.
It is named "deep corneal deposits" rather than "PDCD" deliberately. Much of
the ophthalmological literature - including every primary report cited here -
calls these cases PDCD, but IC3D expressly refuses the label because XLI is a
systemic disease with corneal manifestations. The subtype is retained under
this MONDO concept because that is how the clinical literature indexes it,
with the dissent recorded as evidence rather than suppressed.
genes:
- preferred_term: STS
term:
id: hgnc:11425
label: STS
evidence:
- reference: PMID:37287641
reference_title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The slit-lamp examination of three affected men (two of whom were
brothers) from two families revealed bilateral punctate posterior corneal
stromal opacities anterior to the Descemet membrane.
explanation: >-
Defines the corneal phenotype of this subtype in genetically confirmed
individuals.
- reference: PMID:37287641
reference_title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
PDCD with XLI may be associated with either partial or complete deletion
of STS.
explanation: >-
States the allelic spectrum that defines this subtype, and shows the
primary literature does apply the PDCD label to it.
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: REFUTE
evidence_source: OTHER
snippet: >-
Similar deep corneal deposits to PDCD are also frequently seen in X-linked
ichthyosis (MIM #308100) which results from mutations in the steroid
sulfatase gene (STS) at genetic locus Xp22.31.
explanation: >-
IC3D describes these deposits as merely SIMILAR to PDCD rather than as
PDCD, which is the first half of its refusal to classify them together.
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: REFUTE
evidence_source: OTHER
snippet: >-
This is a systemic disease with corneal manifestations and therefore is
not a corneal dystrophy.
explanation: >-
The explicit IC3D position that this arm is not a corneal dystrophy at
all - recorded as REFUTE against its inclusion as a subtype of PDCD.
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
It has been described in the first decade of life.
explanation: >-
Gives the early onset of this arm, in contrast to the post-30 onset of
isolated PDCD - a practical discriminator between the two.
inheritance:
- name: X-linked recessive inheritance
inheritance_term:
preferred_term: X-linked recessive inheritance
term:
id: HP:0001419
label: X-linked recessive inheritance
description: >-
In the XLI-associated subtype the lesion is at Xp22.3 and the reported
affected individuals are men, including two brothers in one family. The
corneal finding therefore segregates with X-linked ichthyosis itself, whose
causative gene STS lies at that locus. This inheritance block describes the
XLI-associated arm only; isolated PDCD has no established mode of
inheritance, which is part of why IC3D rates it category 4.
evidence:
- reference: PMID:37287641
reference_title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Genetic examination of the STS locus on the X chromosome in Case 1
revealed a deletion that spanned across DNA markers DXS1130-DXS237, which
includes all the coding exons (exons 1-10) of STS.
explanation: >-
Places the causal lesion on the X chromosome in an affected male.
- reference: PMID:39086014
reference_title: "Revisiting X-linked congenital ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The causative gene for XLI is the steroid sulfatase gene (STS), located on
Xp22.3.
explanation: >-
Confirms the gene and cytoband of the associated X-linked disorder.
pathophysiology:
- name: Keratocyte Lysosomal Lipofuscin-Like Lipoprotein Accumulation
biological_scale: MOLECULAR
role: trigger
mechanism_confidence: PROVISIONAL
subtypes:
- Isolated PDCD
description: >-
The proposed initiating lesion of the isolated arm, and the reason that arm
reads as a degeneration. Transmission electron microscopy of PDCD corneas
shows membrane-bound intracellular vacuoles containing electron-dense
material that has the appearance of secondary lysosomes, together with
inclusions of a lipofuscin-like lipoprotein. Lipofuscin is the classic
marker of accumulated, incompletely degraded material in long-lived
post-mitotic cells, and its presence is what the reporting authors read as
evidence of a degenerative process rather than of a genetically determined
storage product. Consistent with that, onset is usually after age 30.
It is curated PROVISIONAL rather than established because IC3D itself
reports that the histopathological studies of PDCD are not consistent, and
because no gene, locus or metabolic defect has been assigned that would
explain why the material accumulates.
cellular_components:
- preferred_term: lysosome
modifier: INCREASED
term:
id: GO:0005764
label: lysosome
cell_types:
- preferred_term: Posterior stromal keratocyte
term:
id: CL:0002363
label: keratocyte
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Membrane-bound intracellular vacuoles containing electron-dense material
suggestive of secondary lysosomes and inclusions of a lipofuscin-like
lipoprotein consistent with a degenerative process are seen in PDCD.
explanation: >-
The ultrastructural basis of this node, including the authors' own reading
of it as degenerative.
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Histopathologic studies of PDCD are not consistent.
explanation: >-
The explicit caveat that makes this node provisional rather than
established.
- reference: PMID:31298040
reference_title: "Multimodal imaging of pre-Descemet corneal dystrophy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The clinical presentation and structural anomalies found in isolated
sporadic pre-Descemet corneal dystrophy are in favor of a degenerative
process affecting corneal keratocytes with no epithelial or endothelial
involvement.
explanation: >-
An independent in vivo imaging series reaching the same degenerative,
keratocyte-centred conclusion.
downstream:
- target: Intracellular Deposition in Posterior Keratocytes
causal_link_type: DIRECT
description: >-
Undegraded lipoprotein retained in secondary lysosomes is the material
that renders the keratocyte hyperreflective.
- name: Loss of Steroid Sulfatase Function
biological_scale: MOLECULAR
role: trigger
mechanism_confidence: ESTABLISHED
subtypes:
- XLI-Associated Deep Corneal Deposits
description: >-
The trigger of the genetically characterised arm. STS at Xp22.31 encodes
steroid sulfatase, the enzyme that hydrolyses cholesterol sulfate,
dehydroepiandrosterone sulfate and estrone sulfate. Three classes of lesion
have been found in families with pre-Descemet deposits and X-linked
ichthyosis - point mutations, partial deletions removing some of the ten
coding exons, and complete deletion of the locus, in one case a 4.4 Mb
hemizygous deletion taking three further genes with it. The informative
observation is that the corneal phenotype does not differ between these
classes, which is the argument that all of them converge on loss of enzyme
function rather than on some deletion-size-dependent contiguous-gene effect.
genes:
- preferred_term: STS
term:
id: hgnc:11425
label: STS
genetic_context:
functional_impact_category: LOSS_OF_FUNCTION
variant_origin: GERMLINE
zygosity: HEMIZYGOUS
description: >-
Hemizygous point mutations, partial deletions (exons 1-7 reported) and
complete deletions of STS at Xp22.31 in affected males.
molecular_functions:
- preferred_term: steryl-sulfatase activity
modifier: LOSS_OF_FUNCTION
term:
id: GO:0004773
label: steryl-sulfatase activity
evidence:
- reference: PMID:37287641
reference_title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Genetic screening of Cases 2 and 3 revealed a partial deletion of the STS
locus involving exons 1-7 and flanking DNA marker DXS1130 on the X
chromosome.
explanation: >-
Documents a partial-deletion allele in two affected brothers.
- reference: PMID:37287641
reference_title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Despite the identification of point mutations, partial deletion, and
complete deletion of STS in different affected families reported to date,
there was no apparent difference in the affected phenotype between the
families, suggesting that the identified variants likely all resulted in
loss of function of steroid sulfatase.
explanation: >-
The allelic-heterogeneity-with-uniform-phenotype argument that identifies
loss of enzyme function, rather than deletion extent, as the mechanism.
- reference: PMID:23807007
reference_title: "Pre-Descemet corneal dystrophy and X-linked ichthyosis associated with deletion of Xp22.31 containing the STS gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
aCGH performed on genomic DNA revealed a microdeletion in the Xp22.31
cytoband of approximately 1.7 megabases, containing STS.
explanation: >-
Documents a whole-locus microdeletion in an affected individual.
- reference: PMID:28302098
reference_title: "In vivo confocal microscopy of pre-Descemet corneal dystrophy associated with X-linked ichthyosis: a case report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
PCR results demonstrated that all ten exons and part flanking sequences of
STS gene failed to produce any amplicons in the patient.
explanation: >-
Independent confirmation of complete loss of the STS coding sequence in a
patient with pre-Descemet deposits.
downstream:
- target: Cholesterol Sulfate Accumulation
causal_link_type: DIRECT
description: >-
Steroid sulfatase is the enzyme that hydrolyses cholesterol sulfate, so
its loss allows the substrate to accumulate.
evidence:
- reference: PMID:39086014
reference_title: "Revisiting X-linked congenital ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
STS deficiency causes an abnormal cholesterol sulfate (CS) accumulation
in the stratum corneum (SC).
explanation: >-
Establishes the enzyme-to-substrate step, demonstrated in skin.
- name: Cholesterol Sulfate Accumulation
biological_scale: MOLECULAR
role: central_effector
mechanism_confidence: PROVISIONAL
subtypes:
- XLI-Associated Deep Corneal Deposits
description: >-
Steroid sulfatase hydrolyses cholesterol sulfate, so loss of the enzyme
allows the sulfated sterol to accumulate. This is firmly established in the
skin, where excess cholesterol sulfate in the stratum corneum is what
produces the barrier dysfunction and scaling of X-linked ichthyosis, and it
is the natural candidate for the corneal deposit as well.
It is curated as PROVISIONAL because that last step is an inference, and
because there is a competing candidate. No study has chemically identified
the material inside the posterior keratocytes of an STS-deficient cornea;
what has been shown is that the deposit is there, that it is intracellular,
and that the patient lacks steroid sulfatase. Meanwhile the ultrastructural
material characterised in isolated PDCD is a lipofuscin-like lipoprotein,
not a sulfated sterol. Whether the two arms share a stored substance or
merely a location is unresolved, and the knowledge-gap discussion on this
entry keeps that open rather than assuming it.
chemical_entities:
- preferred_term: cholesterol sulfate
modifier: INCREASED
term:
id: CHEBI:41321
label: cholesterol sulfate
evidence:
- reference: PMID:39086014
reference_title: "Revisiting X-linked congenital ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
STS deficiency causes an abnormal cholesterol sulfate (CS) accumulation in
the stratum corneum (SC).
explanation: >-
Establishes substrate accumulation as the direct consequence of enzyme
loss - but in stratum corneum, not cornea. Recorded as PARTIAL rather than
SUPPORT so the support level itself carries the tissue mismatch, instead of
leaving it to the surrounding prose.
- reference: PMID:39086014
reference_title: "Revisiting X-linked congenital ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Excess CS induces epidermal permeability barrier dysfunction and scaling
abnormalities.
explanation: >-
Shows the downstream consequence of the accumulated substrate is
characterised in epidermis, not in cornea - the reason this node is
provisional for the eye.
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
inclusions of a lipofuscin-like lipoprotein consistent with a degenerative
process are seen in PDCD
explanation: >-
The competing substrate identity characterised in isolated PDCD, which is
why a shared cholesterol-sulfate deposit cannot be assumed across both
arms.
downstream:
- target: Intracellular Deposition in Posterior Keratocytes
causal_link_type: DIRECT
description: >-
Accumulated sulfated sterol is the proposed identity of the
hyperreflective material seen within posterior keratocytes in this arm;
the link is inferred from skin, not demonstrated in cornea.
- name: Intracellular Deposition in Posterior Keratocytes
biological_scale: CELLULAR
role: central_effector
mechanism_confidence: ESTABLISHED
description: >-
The shared cellular lesion, and the observation that most sharply separates
this entity from the classical stromal dystrophies. In vivo confocal
microscopy shows enlarged, hyperreflective keratocytes in the posterior
stroma carrying intracellular dots, with activated keratocytes as far
forward as the very anterior stroma; the same is seen in the STS-deficient
arm, where hyperreflective particles sit inside enlarged and activated
posterior keratocytes. The stromal dystrophies in the same MONDO branch -
macular, Schnyder, congenital stromal, the TGFBI forms - deposit abnormal
material in the extracellular matrix and progressively opacify the cornea.
Here the cell is the affected compartment, the cells are enlarged and
activated rather than lost, and the epithelium and endothelium are spared.
The extracellular contribution is not nil, and the entry does not pretend
otherwise: diffuse small extracellular stromal deposits are described in
vivo, even though transmission electron microscopy of PDCD reports none.
That is one of the inconsistencies IC3D flags in the histopathology.
cell_types:
- preferred_term: Posterior stromal keratocyte
term:
id: CL:0002363
label: keratocyte
locations:
- preferred_term: Corneal stroma
term:
id: UBERON:0001777
label: substantia propria of cornea
evidence:
- reference: PMID:31298040
reference_title: "Multimodal imaging of pre-Descemet corneal dystrophy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Diffuse small extracellular stromal deposits, presence of enlarged
hyperreflective keratocytes in the posterior stroma with either
hyperreflective or hyporeflective intracellular dots, and presence of
activated keratocytes in the very anterior stroma were observed in all
corneas with in vivo confocal microscopy.
explanation: >-
The defining cellular finding, present in all eight corneas of a
four-patient series, including the extracellular component.
- reference: PMID:28302098
reference_title: "In vivo confocal microscopy of pre-Descemet corneal dystrophy associated with X-linked ichthyosis: a case report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
IVCM revealed regular distributed hyperreflective particles inside the
enlarged and activated keratocytes in the posterior stroma.
explanation: >-
The same intracellular posterior-keratocyte lesion in the STS-deficient
arm, which is what makes the two arms clinically indistinguishable.
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Normal cornea except for enlarged keratocytes in the posterior stroma
containing vacuoles and intracytoplasmic inclusions of lipid-like
material.
explanation: >-
Light-microscopic confirmation that the abnormality is confined to
enlarged, inclusion-bearing posterior keratocytes.
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
No extracellular deposits are noted.
explanation: >-
The electron-microscopic finding of no extracellular deposit, which
conflicts with the in vivo confocal observation of diffuse extracellular
deposits and is recorded here rather than reconciled.
downstream:
- target: Deep Stromal Punctate Opacification Anterior to Descemet Membrane
causal_link_type: DIRECT
description: >-
Light-scattering, particle-laden keratocytes concentrated in the deepest
stroma are what the slit lamp resolves as discrete punctate opacities.
- name: Deep Stromal Punctate Opacification Anterior to Descemet Membrane
biological_scale: TISSUE
role: consequence
mechanism_confidence: ESTABLISHED
description: >-
The tissue-level endpoint and the diagnostic finding: focal, fine,
polymorphic grey opacities - central, annular or diffuse - confined to the
deep stroma immediately anterior to Descemet membrane, bilaterally.
Cross-sectional imaging resolves the same thing as a hyperreflective line
running limbus to limbus just anterior to Descemet's membrane, and
Scheimpflug tomography shows a second, posterior light-scattering peak that
does not belong in a normal cornea.
The name is a slight misdescription that is worth stating explicitly: the
opacities are visible pre-Descemet, but multimodal imaging finds fine
hyperreflective particles through the posterior, mid and anterior stroma.
The disorder affects the whole stroma; the pre-Descemet location is where
the damage is maximal, not where it is confined.
locations:
- preferred_term: Descemet's membrane
term:
id: UBERON:0004367
label: Descemet's membrane
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Focal, fine, polymorphic gray opacities that may be central, annular, or
diffuse are visible in the deep stroma immediately anterior to Descemet
membrane
explanation: >-
The reference description of the defining lesion and its variants.
- reference: PMID:31298040
reference_title: "Multimodal imaging of pre-Descemet corneal dystrophy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Spectral domain optical coherence tomography scans showed a
hyperreflective line anterior to Descemet's membrane running from limbus
to limbus and associated with a second thinner hyperreflective line just
beneath Bowman's layer.
explanation: >-
Confirms the depth-restricted lesion on cross-sectional imaging and
records a second anterior line, evidence that the process is not confined
posteriorly.
- reference: PMID:31298040
reference_title: "Multimodal imaging of pre-Descemet corneal dystrophy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Multimodal imaging of cornea reveals that the disorder affects the whole
stroma
explanation: >-
Directly qualifies the "pre-Descemet" name: the visible opacities are
deep, but the process is panstromal.
- reference: PMID:32482962
reference_title: "Multimodal Imaging of Pre-Descemet Corneal Dystrophy Associated With X-Linked Ichthyosis and Deletion of the STS Gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Scheimpflug tomography revealed a bimodal peak light scattering.
explanation: >-
Provides an objective optical measurement of the extra posterior
scattering layer.
downstream:
- target: Visually Silent Corneal Finding
causal_link_type: DIRECT
description: >-
Because the opacities are fine, deep and non-confluent they do not degrade
the retinal image, so the finding presents as a sign rather than as visual
loss.
- name: Visually Silent Corneal Finding
biological_scale: ORGANISM
role: consequence
mechanism_confidence: ESTABLISHED
description: >-
The organism-level outcome, unusual in being an absence of disability.
Vision is usually unaffected and patients are typically asymptomatic, so
PDCD requires no treatment; IC3D lists it among the dystrophies that are
typically asymptomatic and need none. The qualifier "usually" is theirs and
is kept here, because one adult in a recently described pedigree did
complain of glare.
The clinical value of the finding is therefore diagnostic rather than
therapeutic, and it runs in both directions: pre-Descemet opacities in a
male - especially a child, since the XLI-associated deposits appear in the
first decade - are a reason to examine the skin and consider copy-number
analysis of STS, and known ichthyosis is a reason to look at the cornea.
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Vision is usually unaffected, and patients are typically asymptomatic. One
adult member of a recently described pedigree complained of glare.
explanation: >-
States the visual outcome together with the single reported exception.
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Several corneal dystrophies including FCD, PACD, CCDF, and PDCD are
typically asymptomatic and do not require treatment.
explanation: >-
Establishes that no treatment is indicated, which is why this entry
curates none.
- reference: PMID:32482962
reference_title: "Multimodal Imaging of Pre-Descemet Corneal Dystrophy Associated With X-Linked Ichthyosis and Deletion of the STS Gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This report demonstrates that PDCD-associated XLI may present in children
and that the diagnosis may be confirmed through multimodal imaging in
conjunction with genetic analysis.
explanation: >-
Establishes the diagnostic value of the corneal sign, including its
presence in childhood.
- reference: PMID:23807007
reference_title: "Pre-Descemet corneal dystrophy and X-linked ichthyosis associated with deletion of Xp22.31 containing the STS gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The identification of a microdeletion within Xp22.3 containing STS with
aCGH in an individual with suspected pre-Descemet corneal dystrophy and
X-linked ichthyosis demonstrates the clinical utility of copy number
variation analysis in confirming a presumptive clinical diagnosis.
explanation: >-
States the clinical use of the finding: it converts a presumptive
diagnosis into a confirmed one via copy-number analysis.
phenotypes:
- category: Ophthalmologic
name: Punctate Posterior Stromal Corneal Opacities
description: >-
Numerous fine, polymorphic, punctate opacities in the deep corneal stroma
immediately anterior to Descemet membrane, bilateral. This is the defining
finding of the entity; its depth restriction is what makes the diagnosis.
phenotype_term:
preferred_term: Punctate opacification of the cornea
term:
id: HP:0007856
label: Punctate opacification of the cornea
diagnostic: true
evidence:
- reference: PMID:37287641
reference_title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The slit-lamp examination of three affected men (two of whom were
brothers) from two families revealed bilateral punctate posterior corneal
stromal opacities anterior to the Descemet membrane.
explanation: >-
Documents the bilateral punctate posterior stromal opacities in three
genetically confirmed affected men.
- reference: PMID:23807007
reference_title: "Pre-Descemet corneal dystrophy and X-linked ichthyosis associated with deletion of Xp22.31 containing the STS gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The slit-lamp examination revealed punctate opacities in the posterior
corneal stroma of each eye.
explanation: >-
Independent documentation of the same bilateral finding.
- category: Ophthalmologic
name: Abnormal Posterior Corneal Stroma
description: >-
The structural abnormality underlying the visible opacities: enlarged,
activated keratocytes in the posterior stroma laden with hyperreflective
intracellular particles.
notes: >-
Carried alongside the punctate-opacity phenotype (HP:0007856) on purpose,
even though HP:0011492 is that term's generic ancestor. The two record
different observations at different resolutions: HP:0007856 is what the slit
lamp sees (discrete grey punctae at a defined depth), while this entry is
what confocal microscopy sees (enlarged, activated, particle-laden
keratocytes). HPO has no term for the latter, so the generic parent is the
closest available anchor and the specificity lives in the description. If a
keratocyte-inclusion term is ever added, this binding should move to it.
phenotype_term:
preferred_term: Abnormal corneal stroma morphology
term:
id: HP:0011492
label: Abnormal corneal stroma morphology
evidence:
- reference: PMID:28302098
reference_title: "In vivo confocal microscopy of pre-Descemet corneal dystrophy associated with X-linked ichthyosis: a case report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Slit-lamp biomicroscopy showed the presence of tiny and pleomorphic
opacities in the posterior stroma immediately anterior to Descemet
membrane bilaterally.
explanation: >-
Documents the abnormal posterior stromal morphology on which the confocal
findings were made.
- category: Dermatologic
name: Ichthyosis
description: >-
Dry, coarse, scaling skin, most marked on the extensor surfaces of the
limbs. In the XLI-associated subtype this is not a comorbidity but the same
disorder seen in a second organ, and it is what makes the corneal finding
diagnostically actionable.
subtype: XLI-Associated Deep Corneal Deposits
phenotype_term:
preferred_term: Ichthyosis
term:
id: HP:0008064
label: Ichthyosis
evidence:
- reference: PMID:37287641
reference_title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Cutaneous examination demonstrated dry, coarse, scaly ichthyotic changes
characteristic of XLI in all individuals.
explanation: >-
Documents the ichthyotic skin phenotype in every affected individual of
the two families.
- reference: PMID:28302098
reference_title: "In vivo confocal microscopy of pre-Descemet corneal dystrophy associated with X-linked ichthyosis: a case report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Dermatological examination revealed that the skin over the patient's
entire body was dry and coarse, with thickening and scaling of the skin in
the extensor side of the extremities.
explanation: >-
Records the distribution of the ichthyotic changes in a PDCD patient.
- category: Ophthalmologic
name: Glare
description: >-
Vision is usually unaffected in this entity, but not invariably: one adult
member of a recently described pedigree complained of glare. Recorded
because "asymptomatic" is the entity's defining clinical claim, and a single
documented exception to it is worth carrying rather than rounding away.
phenotype_term:
preferred_term: Glare
notes: >-
Left unbound deliberately. HPO has no term for glare - light scatter
degrading image quality - and the nearest candidate, Photophobia
(HP:0000613), is defined as "Excessive sensitivity to light with the
sensation of discomfort or pain in the eyes due to exposure to bright
light", which is a different complaint from glare produced by a
light-scattering cornea. `sqlite:obo:hp` was searched for "glare" and for
the Photophobia and abnormal-visual-function neighbourhoods; no suitable
term exists. `frequency` is likewise omitted: the source describes a single
adult in one pedigree, which is below the resolution of any FrequencyEnum
band.
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Vision is usually unaffected, and patients are typically asymptomatic. One
adult member of a recently described pedigree complained of glare.
explanation: >-
Records the single reported symptomatic individual against the general
statement that patients are asymptomatic.
histopathology:
- name: Enlarged Posterior Keratocytes with Intracytoplasmic Lipid-Like Inclusions
description: >-
Light microscopy of a PDCD cornea is normal apart from the posterior
keratocytes, which are enlarged and contain vacuoles and intracytoplasmic
inclusions of lipid-like material. The negative half of that description is
as informative as the positive half: epithelium, Bowman layer, Descemet
membrane and endothelium are unremarkable, so the lesion is a keratocyte
lesion and not a corneal one in general.
diagnostic: true
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Normal cornea except for enlarged keratocytes in the posterior stroma
containing vacuoles and intracytoplasmic inclusions of lipid-like
material.
explanation: >-
The reference light-microscopic description of PDCD.
- name: Membrane-Bound Vacuoles with Lipofuscin-Like Lipoprotein on Electron Microscopy
description: >-
Transmission electron microscopy resolves the vacuoles as membrane-bound
structures containing electron-dense material with the appearance of
secondary lysosomes, plus inclusions of a lipofuscin-like lipoprotein - a
pattern the reporting authors read as degenerative. No extracellular
deposits are seen. That is the ultrastructural point on which PDCD parts
company with the classical stromal dystrophies, every one of which is
defined by extracellular accumulation.
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Membrane-bound intracellular vacuoles containing electron-dense material
suggestive of secondary lysosomes and inclusions of a lipofuscin-like
lipoprotein consistent with a degenerative process are seen in PDCD. No
extracellular deposits are noted.
explanation: >-
The ultrastructural description, including the absence of extracellular
deposit.
- name: Inconsistent Histopathology Across Reported Cases
description: >-
Recorded as a finding in its own right because it constrains every other
histopathological claim on this entry. IC3D states that the
histopathological studies of PDCD are not consistent, which is part of why
the entity sits in category 4 and why the ultrastructural mechanism above is
curated as provisional rather than established.
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Histopathologic studies of PDCD are not consistent.
explanation: >-
The classifying committee's own assessment of the reliability of the
histopathology.
imaging_findings:
- name: Pre-Descemet Hyperreflective Line on OCT
modality: OCT
description: >-
Spectral-domain OCT shows a hyperreflective line immediately anterior to
Descemet's membrane running limbus to limbus, with a second, thinner line
beneath Bowman's layer and fine hyperreflective particles distributed
through the posterior, mid and anterior stroma.
evidence:
- reference: PMID:31298040
reference_title: "Multimodal imaging of pre-Descemet corneal dystrophy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Fine hyperreflective particles were observed in the posterior, mid, and
anterior stroma on optical coherence tomography scans.
explanation: >-
Documents the panstromal distribution of particles on OCT, beyond the
pre-Descemet line that names the entity.
- reference: PMID:32482962
reference_title: "Multimodal Imaging of Pre-Descemet Corneal Dystrophy Associated With X-Linked Ichthyosis and Deletion of the STS Gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A pre-Descemet hyper-reflective line, consistent with these opacities, was
seen with anterior segment optical coherence tomography.
explanation: >-
Independent documentation of the pre-Descemet line in the STS-deficient
arm.
differential_diagnoses:
- name: Cornea farinata
description: >-
An age-related degeneration producing many fine, dust-like grey-brown to
white opacities bilaterally in the posterior stroma near Descemet membrane,
best seen on retroillumination. IC3D includes it in the same template as
PDCD, and the distinction from isolated PDCD is not sharp - the IC3D text
treats "cornea farinata" as a name applied to the same finding.
distinguishing_features:
- >-
Opacities are finer and more dust-like than those of PDCD, and are best seen
on retroillumination; confocal shows highly reflective particles in the
cytoplasm of some keratocytes but only in the deep stroma, whereas in PDCD
hyperreflective inclusions are both intracellular and extracellular.
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In the degenerative condition, cornea farinata, many fine, dust-like
gray-brown to white opacities are best seen on retroillumination and are
located bilaterally in the posterior stroma near Descemet membrane.
explanation: >-
Describes the appearance that has to be distinguished from PDCD.
- name: Punctiform and polychromatic pre-Descemet corneal dystrophy (PPPCD)
description: >-
A separate entity, IC3D category 1, autosomal dominant, caused by PRDX3
variants at 10q26.11, with its own MONDO term (MONDO:0859248) and OMIM entry
(#619871). It occupies the same corneal layer as PDCD and is the single most
likely thing to be confused with it. Nothing about PRDX3 is curated on this
entry.
distinguishing_features:
- >-
PPPCD deposits are polychromatic, larger and more punctate, and more uniform
within an otherwise normal cornea; onset can be as young as age 3 against
PDCD's usual onset after 30; PPPCD is non-progressive or mildly progressive
where other forms of PDCD progress; and PPPCD has an identified gene and
autosomal dominant pedigrees where PDCD has neither.
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In PPPCD, the pre-Descemet deposits are more uniform and polychromatic
within the otherwise normal cornea.
explanation: >-
Gives the phenotypic distinction between PPPCD and PDCD.
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
PPPCD is nonprogressive or possibly shows mild progression. Other forms of
PDCD show progression.
explanation: >-
Gives the progression distinction between the two entities.
- name: Similar deep opacities in other ocular and systemic disease
description: >-
Deep pre-Descemet opacities are not specific to this entity. IC3D notes
similar opacities in pseudoxanthoma elasticum, keratoconus, posterior
polymorphous corneal dystrophy, epithelial basement membrane dystrophy and
central cloudy dystrophy of Francois. The finding is therefore a starting
point for a differential rather than a diagnosis on its own.
distinguishing_features:
- >-
Each of these carries its own additional corneal or systemic findings;
isolated PDCD is a diagnosis of exclusion once they are absent.
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Similar opacities have been noted in association with other ocular and
systemic diseases such as pseudoxanthoma elasticum, keratoconus, posterior
polymorphous corneal dystrophy (PPCD), EBMD, and central cloudy dystrophy
of François (CCDF).
explanation: >-
Enumerates the conditions in which the same corneal appearance occurs.
progression:
- phase: Onset
subtype: Isolated PDCD
notes: >-
Isolated PDCD usually appears after the age of 30, which is one of the
practical discriminators from the XLI-associated deposits (first decade) and
from PPPCD (reported as young as 3).
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Usually after age 30 years; although PPPCD has been found in children as
young as age 3 years.
explanation: >-
Gives the age of onset for this entity, with the contrast to PPPCD.
- phase: Onset
subtype: XLI-Associated Deep Corneal Deposits
notes: >-
The deep corneal deposits of X-linked ichthyosis have been described in the
first decade of life, and a genetically confirmed case has been reported in
an 11-year-old boy - so an early-onset pre-Descemet finding should prompt a
skin examination rather than a diagnosis of isolated PDCD.
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
It has been described in the first decade of life.
explanation: >-
Gives the age of onset of the STS-associated arm.
genetic:
- name: STS
gene_term:
preferred_term: STS
term:
id: hgnc:11425
label: STS
relationship_type: CAUSATIVE
variant_origin: GERMLINE
presence: PRESENT
subtype: XLI-Associated Deep Corneal Deposits
notes: >-
STS (Xp22.3) encodes steroid sulfatase. It is the causative gene of X-linked
ichthyosis, and every genetically characterised PDCD family reported to date
carries an STS lesion. Three allele classes have been described in PDCD
specifically - point mutations, partial deletion of the coding exons (exons
1-7 in one family of two brothers), and complete deletion of the locus,
including a 4389 kbp hemizygous deletion that removed four genes. The
phenotype does not differ between these classes, which argues that all act
through loss of enzyme function rather than through the extra genes a large
deletion removes. Note the scope limit: STS is causative for the
XLI-associated arm only. Isolated PDCD has no identified gene, and IC3D
places it in category 4 for that reason.
evidence:
- reference: PMID:37287641
reference_title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Pre-Descemet corneal dystrophy (PDCD) with X-linked ichthyosis (XLI) is
associated with mutations in or deletions of the steroid sulfatase gene
(STS).
explanation: >-
States the gene-disease association for the XLI-associated arm.
- reference: PMID:37287641
reference_title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
As only three cases of genetically confirmed PDCD associated with XLI have
been reported, we sought to expand our understanding of the genetic basis
of PDCD by screening STS in two previously unreported families.
explanation: >-
Records how few genetically confirmed cases existed, which bounds the
strength of the gene-disease claim.
- reference: PMID:32482962
reference_title: "Multimodal Imaging of Pre-Descemet Corneal Dystrophy Associated With X-Linked Ichthyosis and Deletion of the STS Gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Copy number analysis identified a 4389 kbp hemizygous deletion on the X
chromosome (chr. X: 6,540,898-8,167,604), resulting in the deletion of 4
genes, including the known locus of XLI, the STS gene.
explanation: >-
Documents a large contiguous deletion encompassing STS in a PDCD patient.
animal_models:
- name: Spontaneous canine posterior stromal dystrophy (comparative phenocopy)
species: Canis lupus familiaris
genotype: Not determined - no orthologous mutation demonstrated
publication: PMID:35346188
description: >-
A naturally occurring canine case, not an engineered model, and included here
for what it does and does not establish. In vivo confocal microscopy of a dog
with bilateral, non-inflammatory posterior corneal stromal opacities showed
hyperreflective deposits inside keratocytes, with the number of enlarged
deposit-containing keratocytes increasing toward the posterior stroma - the
same cellular pattern, in the same corneal layer, with the same
posterior-increasing gradient described in human PDCD. The reporting
ophthalmologists say so themselves.
No gene was identified and no orthologous variant demonstrated, so this is a
comparative phenocopy rather than a validated natural model.
modeled_mechanisms:
- target: Intracellular Deposition in Posterior Keratocytes
relationship: PARTIALLY_RECAPITULATES
fidelity: LOW
description: >-
The canine cornea reproduces the cellular lesion this node curates -
intracellular hyperreflective deposits in enlarged posterior keratocytes,
graded toward Descemet membrane - independently of any human tissue.
limitations: >-
A single spontaneous case with no genotype: no STS variant, no orthologous
mutation of any kind, and no demonstration that the stored material is the
same. The resemblance is at the level of imaging phenotype only, and the
reporting authors describe it as "reminiscent of" rather than as the same
disease. It therefore cannot support any causal or therapeutic inference
about the human entity; its value is that the cellular pattern recurs in a
second species, which is weak evidence that the pattern is a real
biological entity rather than an artefact of human imaging convention.
readouts:
- name: Intra-keratocyte hyperreflective deposits on in vivo confocal microscopy
target: Intracellular Deposition in Posterior Keratocytes
direction: INCREASED
interpretation: >-
Deposits are intracellular and the affected keratocytes are enlarged,
matching the human confocal description.
evidence:
- reference: PMID:35346188
reference_title: "Multimodal ocular imaging of known and novel corneal stromal disorders in dogs."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
With IVCM, hyperreflective deposits were identified within keratocytes
and the number of enlarged keratocytes containing hyperreflective
deposits increased towards the posterior stroma.
explanation: >-
The confocal readout, including the posterior-increasing gradient that
matches the human lesion.
evidence:
- reference: PMID:35346188
reference_title: "Multimodal ocular imaging of known and novel corneal stromal disorders in dogs."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
The bilateral, non-inflammatory nature and unique appearance with IVCM is
most consistent with a posterior stromal dystrophy reminiscent of
pre-Descemet corneal dystrophy described in humans.
explanation: >-
The authors' own comparison to human PDCD, stated as a resemblance rather
than an identity - which is exactly the strength of claim this link
makes.
notes: >-
Recorded deliberately at LOW fidelity with `PARTIALLY_RECAPITULATES` rather
than omitted or overstated. The deep-research report for this entry mentioned
the observation but gave no identifier; the PMID was recovered by an
independent PubMed search and the abstract read before curating.
diagnosis:
- name: Slit-Lamp Biomicroscopy
description: >-
The primary diagnostic examination. Depth is what matters: fine punctate
opacities confined to the stroma immediately anterior to Descemet membrane,
bilaterally, distinguish PDCD from opacities at any other corneal level.
evidence:
- reference: PMID:32482962
reference_title: "Multimodal Imaging of Pre-Descemet Corneal Dystrophy Associated With X-Linked Ichthyosis and Deletion of the STS Gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Corneal opacities characteristic of PDCD located in the posterior corneal
stroma just anterior to Descemet membrane were identified by slit-lamp
biomicroscopy.
explanation: >-
Establishes slit-lamp biomicroscopy as the examination that makes the
diagnosis.
- name: In Vivo Confocal Microscopy
description: >-
Resolves the lesion at cellular level, showing the hyperreflective particles
within enlarged and activated posterior keratocytes. This is what
distinguishes PDCD mechanistically from the extracellular-deposition stromal
dystrophies, and it is the modality that can characterise a lesion too fine
for other techniques. It is not universally informative: in one reported
child with genetically confirmed PDCD the confocal findings were
unremarkable while slit-lamp, AS-OCT and Scheimpflug were all abnormal.
evidence:
- reference: PMID:28302098
reference_title: "In vivo confocal microscopy of pre-Descemet corneal dystrophy associated with X-linked ichthyosis: a case report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In vivo confocal microscopy (IVCM) is a useful tool to examine the minimal
lesions of the cornea at the cellular level.
explanation: >-
States the diagnostic role of the modality for lesions of this scale.
- reference: PMID:32482962
reference_title: "Multimodal Imaging of Pre-Descemet Corneal Dystrophy Associated With X-Linked Ichthyosis and Deletion of the STS Gene."
supports: REFUTE
evidence_source: HUMAN_CLINICAL
snippet: >-
In vivo confocal microscopy findings were unremarkable.
explanation: >-
A negative result in a genetically confirmed case, showing the modality
does not always detect the lesion; recorded so the diagnostic claim is not
overstated.
- name: Copy Number Variation Analysis of STS
description: >-
Array CGH or cytogenomic array analysis of the Xp22.31 region converts a
presumptive clinical diagnosis into a confirmed one. It is the necessary
test rather than exon PCR alone, because the commonest lesion is a deletion
- and a complete deletion produces exactly the same result as failed
amplification for any other reason, so absence of amplicons has to be
followed by copy-number analysis to be interpretable.
evidence:
- reference: PMID:23807007
reference_title: "Pre-Descemet corneal dystrophy and X-linked ichthyosis associated with deletion of Xp22.31 containing the STS gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Polymerase chain reaction amplification using primers designed to amplify
each of the 10 exons of STS failed to produce any amplicons.
explanation: >-
Shows the PCR result that prompted, but could not by itself establish, the
deletion diagnosis.
- reference: PMID:23807007
reference_title: "Pre-Descemet corneal dystrophy and X-linked ichthyosis associated with deletion of Xp22.31 containing the STS gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The identification of a microdeletion within Xp22.3 containing STS with
aCGH in an individual with suspected pre-Descemet corneal dystrophy and
X-linked ichthyosis demonstrates the clinical utility of copy number
variation analysis in confirming a presumptive clinical diagnosis.
explanation: >-
States the diagnostic utility of copy-number analysis for this entity.
prevalence:
- population: >-
Males with X-linked ichthyosis (an upper bound on the XLI-associated
subtype, not a measurement of PDCD)
measure_type: POINT_PREVALENCE
prevalence_class: BAND_1_5_PER_10000
rate_low: 16.7
rate_high: 50.0
subtype: XLI-Associated Deep Corneal Deposits
notes: >-
This is the prevalence of X-linked ichthyosis itself, 1/6,000 to 1/2,000 in
males, recorded deliberately as a ceiling rather than as a measurement. PDCD
occurs in only some XLI patients, so the true rate of the XLI-associated
subtype is lower by an undetermined factor - the proportion of XLI patients
with pre-Descemet opacities is not established in the cited literature, and
is not invented here. The prevalence of isolated PDCD is not documented at
all.
evidence:
- reference: PMID:39086014
reference_title: "Revisiting X-linked congenital ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
It is the second most common type of ichthyosis, with a prevalence of
1/6,000 to 1/2,000 in males and without any racial or geographical
differences.
explanation: >-
Gives the prevalence of the associated skin disorder, which bounds the
XLI-associated subtype from above but does not measure it.
discussions:
- discussion_id: pdcd_deposit_identity
kind: KNOWLEDGE_GAP
status: OPEN
prompt: >-
Do the two arms of this entity store the same material - and specifically,
is the deposit in the STS-deficient cornea cholesterol sulfate, or the same
lipofuscin-like lipoprotein described in isolated PDCD?
attaches_to:
- "pathophysiology#Cholesterol Sulfate Accumulation"
- "pathophysiology#Keratocyte Lysosomal Lipofuscin-Like Lipoprotein Accumulation"
- "pathophysiology#Intracellular Deposition in Posterior Keratocytes"
rationale: >-
The two arms of this entry converge on an identical-looking cellular lesion
from two different proposed substrates, and neither has been measured where
it matters. In the STS-deficient arm, cholesterol sulfate is the natural
candidate, but the accumulation has only ever been demonstrated in the
stratum corneum; no chemical or metabolomic characterisation of an
STS-deficient cornea exists. In the isolated arm, the material that has
actually been characterised ultrastructurally is a lipofuscin-like
lipoprotein in secondary lysosomes - not a sulfated sterol - and IC3D warns
that even those studies are inconsistent.
Three outcomes are possible and they are not equivalent. If both arms store
cholesterol sulfate, the isolated cases become candidates for occult
sulfatase pathway defects. If both store lipofuscin-like lipoprotein, the
STS lesion is acting through a general lysosomal-degradation failure rather
than through its own substrate, and the entity is a degeneration with a
genetic accelerator. If they store different things, the resemblance is
coincidental and the two should not share a MONDO concept at all - which is
close to IC3D's position.
proposed_experiments:
- experiment_id: pdcd_deposit_lipidomics
name: Comparative lipidomics and electron microscopy of PDCD and STS-deficient corneas
description: >-
Apply mass-spectrometry lipidomics and transmission electron microscopy to
corneal tissue from an STS-deleted donor and from a donor with isolated
PDCD, comparing sulfated sterol and lipofuscin content of posterior versus
anterior stroma against age-matched controls, to establish whether the two
arms store the same material.
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Membrane-bound intracellular vacuoles containing electron-dense material
suggestive of secondary lysosomes and inclusions of a lipofuscin-like
lipoprotein consistent with a degenerative process are seen in PDCD.
explanation: >-
Characterises the deposit in isolated PDCD as lipofuscin-like lipoprotein,
which is not the substrate the STS arm predicts.
- reference: PMID:39086014
reference_title: "Revisiting X-linked congenital ichthyosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
STS deficiency causes an abnormal cholesterol sulfate (CS) accumulation in
the stratum corneum (SC).
explanation: >-
The competing substrate, established in skin and never measured in cornea.
- discussion_id: pdcd_entity_boundary_xli
kind: KNOWLEDGE_GAP
status: OPEN
prompt: >-
Should the deep corneal deposits of X-linked ichthyosis be classified as
pre-Descemet corneal dystrophy at all, or as a corneal manifestation of a
systemic disease?
attaches_to:
- "pathophysiology#Loss of Steroid Sulfatase Function"
- "pathophysiology#Intracellular Deposition in Posterior Keratocytes"
rationale: >-
This is a live disagreement between two authorities that this entry
deliberately does not resolve. The primary ophthalmological literature -
every case series cited here, from 2013 through 2023 - labels these cases
"pre-Descemet corneal dystrophy associated with X-linked ichthyosis". IC3D
edition 3 explicitly refuses that label, describing the deposits as merely
similar to PDCD and stating that XLI is a systemic disease with corneal
manifestations and therefore not a corneal dystrophy. MONDO:0017392 carries
the generic name and no gene, so it does not settle the question either way.
It matters for what this record is. If IC3D is right, the STS arm belongs to
an X-linked ichthyosis entry and this concept should shrink to the isolated
category-4 finding; if the clinical literature is right, STS is the only
identified genetic cause of anything called PDCD and the concept's centre of
gravity is the STS arm. The empirical question underneath the nomenclature
is the deposit-identity one recorded separately: if the two arms store
different material, IC3D's separation is vindicated on mechanism and not
merely on classification convention.
proposed_experiments:
- experiment_id: pdcd_xli_corneal_survey
name: Systematic corneal survey of a genotyped X-linked ichthyosis cohort
description: >-
Examine an STS-genotyped XLI cohort with slit lamp, AS-OCT and confocal
microscopy against age-matched controls, quantifying the prevalence,
depth distribution and morphology of pre-Descemet opacities, to establish
whether the XLI corneal phenotype is quantitatively distinguishable from
isolated PDCD rather than only nominally separated from it.
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
This is a systemic disease with corneal manifestations and therefore is
not a corneal dystrophy.
explanation: >-
One side of the disagreement, stated by the classifying committee.
- reference: PMID:37287641
reference_title: "Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis."
supports: REFUTE
evidence_source: HUMAN_CLINICAL
snippet: >-
Pre-Descemet corneal dystrophy (PDCD) with X-linked ichthyosis (XLI) is
associated with mutations in or deletions of the steroid sulfatase gene
(STS).
explanation: >-
The other side: the primary literature treats these cases as PDCD, using
the label IC3D declines to apply.
- discussion_id: pdcd_is_it_a_dystrophy
kind: KNOWLEDGE_GAP
status: OPEN
prompt: >-
Is isolated PDCD a corneal dystrophy at all, or an age-related degeneration
that has been classified with the dystrophies by appearance alone?
attaches_to:
- "pathophysiology#Keratocyte Lysosomal Lipofuscin-Like Lipoprotein Accumulation"
- "pathophysiology#Deep Stromal Punctate Opacification Anterior to Descemet Membrane"
rationale: >-
IC3D assigns PDCD to category 4, the tier reserved for entities with the
least evidence for being a corneal dystrophy, and assigns it no MIM number,
no locus and no gene. The ultrastructure - lipofuscin-like lipoprotein in
secondary lysosomes - is read by the reporting authors as degenerative, an
independent in vivo imaging series reached the same conclusion, and onset
after age 30 fits a degeneration better than a dystrophy.
What keeps the question open rather than closed is that the same source
reports PDCD in families across two to four generations, and that some forms
progress. A purely age-related degeneration should not cluster in pedigrees.
The contrast with the neighbouring entity is instructive: PPPCD occupies the
same corneal layer, has autosomal dominant pedigrees and a gene (PRDX3), and
is rated category 1 - so the classification machinery is capable of
recognising a dystrophy here when the evidence supports one, and has
declined to for PDCD.
proposed_experiments:
- experiment_id: pdcd_age_stratified_prevalence
name: Age-stratified prevalence of pre-Descemet opacities in an unselected population
description: >-
Determine the prevalence of pre-Descemet punctate opacities by decade in
an unselected adult population with slit-lamp and AS-OCT, with STS
copy-number analysis and dermatological examination in those affected. A
prevalence rising steadily with age in individuals without STS lesions
would support degeneration; familial clustering beyond chance would
support dystrophy.
evidence:
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Isolated pre-Descemet corneal dystrophy (PDCD) is neither a well-defined
entity nor is it clearly a hereditary or degenerative disorder (known as
cornea farinata, "flour-like cornea").
explanation: >-
The classifying committee's own statement that the question is unresolved.
- reference: PMID:38359414
reference_title: "IC3D Classification of Corneal Dystrophies-Edition 3."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
PDCD has historically been described as having several subgroups, many of
which may represent sporadic, age-related degenerative and secondary
changes.
explanation: >-
Records the specific suspicion that much of what is called PDCD is
degenerative or secondary rather than a primary dystrophy.
- reference: PMID:31298040
reference_title: "Multimodal imaging of pre-Descemet corneal dystrophy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The clinical presentation and structural anomalies found in isolated
sporadic pre-Descemet corneal dystrophy are in favor of a degenerative
process affecting corneal keratocytes with no epithelial or endothelial
involvement.
explanation: >-
An independent imaging series arguing for the degenerative reading.
notes: >-
Entry-type decision. MONDO:0017392 is a leaf under MONDO:0020213 (stromal
corneal dystrophy), and dismech already has a Stromal_Corneal_Dystrophy
umbrella entry with six subtypes. PDCD was nonetheless curated as its own
Disease rather than folded in as a seventh subtype, because it does not share
that umbrella's pathograph. The umbrella is defined by progressive deposition
of abnormal material in the EXTRACELLULAR matrix causing loss of transparency
and visual impairment; PDCD's material is intracellular, in enlarged posterior
keratocytes, electron microscopy reports no extracellular deposits at all, and
vision is spared. It is linked to the umbrella through `parents` instead.
Entity boundary - PDCD is NOT PPPCD. IC3D edition 3 groups them in one
template but keeps them distinct: punctiform and polychromatic pre-Descemet
corneal dystrophy (PPPCD) is category 1, autosomal dominant, caused by PRDX3
variants at 10q26.11, with MIM #619871; PDCD proper is category 4 with "MIM:
PDCD - None". MONDO keeps them apart too - PPPCD is MONDO:0859248 ("corneal
dystrophy, punctiform and polychromatic pre-descemet"), which is not a
descendant of MONDO:0020213 and is not this entry. Nothing about PRDX3 is
curated here, and a future PPPCD entry should be a separate file rather than a
subtype of this one. This is not a theoretical hazard: the deep-research
report generated for this curation had PRDX3 as its single most-mentioned gene
(27 mentions, ahead of STS at 23) and devoted a whole mechanism subsection to
PPPCD. Nothing from that subsection was used. PPPCD is instead recorded under
`differential_diagnoses`, which is where it belongs.
Scope of the genetic claim. STS is curated as CAUSATIVE for the
XLI-associated arm only. Isolated PDCD has no identified gene and IC3D records
its locus and gene as "Unknown". Note also that the evidence base is small -
the reporting authors describe only three genetically confirmed PDCD-with-XLI
cases before adding their two families - which is why the strength of the
gene-disease relationship is stated with that qualification rather than
asserted flatly.
Deliberately not curated: datasets. `just discover-datasets` returned 12
candidates, all GENE_ONLY and all matched on the string "STS" - which in the
GEO corpus overwhelmingly means *soft tissue sarcoma* or a cell line named
STS-something (H-STS neuroendocrine tumour line, STS-109 undifferentiated
pleomorphic sarcoma), not steroid sulfatase. Not one concerned cornea,
ichthyosis or sulfatase biology. This is Named Entity Confusion reached
through dataset search in its purest form: every accession resolves, and none
is about this disease. No `datasets:` block is therefore recorded, and the
absence is deliberate rather than an omission.
On genetic counselling. A reviewer reasonably suggested a `NCIT:C15240 Genetic
Counseling` treatment scoped to the XLI arm, since that arm is a confirmed
X-linked disorder with recurrence implications for a family. It is not added,
for one reason only: none of the seven cached references contains a quotable
statement about counselling. The closest is PMID:23807007's remark on the
clinical utility of copy-number analysis in confirming a presumptive diagnosis,
which is about diagnosis and is already curated under `diagnosis:`. Adding a
counselling treatment on the strength of it being obviously true is exactly the
fabrication the evidence SOP forbids, so the gap is recorded here instead. If a
citable source is found - a GeneReviews chapter for X-linked ichthyosis would be
the natural one - this is a ready-made addition.
Deliberately not curated: treatments. PDCD is visually silent, and IC3D lists
it among the dystrophies that are typically asymptomatic and do not require
treatment. Recording a treatment here would mean inventing one; the absence is
the clinically relevant fact, and it is carried by evidence on the
"Visually Silent Corneal Finding" node rather than by an empty section.
Scope note. “Pre-Descemet corneal dystrophy” (PDCD) is not one genetically uniform disorder. The 2024 International Committee for Classification of Corneal Dystrophies (IC3D) separates poorly defined, usually sporadic PDCD/cornea farinata-like disease (category 4) from punctiform and polychromatic pre-Descemet corneal dystrophy (PPPCD), a genetically supported autosomal-dominant disorder caused by PRDX3 variants (category 1). Similar deposits can also occur as a manifestation of STS deficiency/X-linked ichthyosis. These entities should not be merged without qualification in a knowledge base. (weiss2024ic3dclassificationof pages 48-49, weiss2024ic3dclassificationof pages 11-12)
| Entity/status | Inheritance / gene / variant | Hallmark phenotype and course | Strongest evidence / sample | Mechanism confidence | Management | Major gaps |
|---|---|---|---|---|---|---|
| Isolated/classic pre-Descemet corneal dystrophy (PDCD), historically overlapping with cornea farinata; IC3D 2024 treats PDCDs as a group and notes isolated PDCD remains poorly defined / category 4 | No established causal gene for isolated PDCD. Usually sporadic in modern imaging series; heredity unclear. IC3D notes prior overlap with cornea farinata/deep filiform/deep punctiform labels. DOI: https://doi.org/10.1097/ICO.0000000000003420 (2024); https://doi.org/10.1177/1120672119862505 (2020) (weiss2024ic3dclassificationof pages 48-49, alafaleq2020multimodalimagingof pages 1-2, alafaleq2020multimodalimagingof pages 4-6) | Bilateral tiny gray/polymorphic punctiform opacities immediately anterior to Descemet membrane; generally asymptomatic with vision usually unaffected; nonprogressive to slowly progressive. Multimodal imaging suggests deposits throughout the stroma, maximal posteriorly. DOI: https://doi.org/10.1097/ICO.0000000000003420 (2024); https://doi.org/10.1177/1120672119862505 (2020) (weiss2024ic3dclassificationof pages 48-49, alafaleq2020multimodalimagingof pages 1-2, alafaleq2020multimodalimagingof pages 6-9) | IC3D expert synthesis plus retrospective multimodal case series of 8 corneas from 4 unrelated male patients with bilateral disease; SD-OCT showed hyperreflective line anterior to Descemet membrane and IVCM showed extracellular stromal deposits plus enlarged posterior keratocytes. DOI: https://doi.org/10.1097/ICO.0000000000003420 (2024); https://doi.org/10.1177/1120672119862505 (2020) (weiss2024ic3dclassificationof pages 48-49, alafaleq2020multimodalimagingof pages 1-2, alafaleq2020multimodalimagingof pages 2-4) | Moderate for a keratocyte-centered degenerative/deposition process; low for a single molecular cause. Evidence includes ultrastructural vacuoles with electron-dense/lipofuscin-like material and imaging evidence of stromal, not epithelial/endothelial, involvement. DOI: https://doi.org/10.1177/1120672119862505 (2020); https://doi.org/10.1097/ICO.0000000000003420 (2024) (weiss2024ic3dclassificationof pages 48-49, alafaleq2020multimodalimagingof pages 6-9, alafaleq2020multimodalimagingof pages 4-6) | Usually observation/follow-up because vision is typically preserved; diagnosis supported by slit-lamp, IVCM, and anterior-segment OCT. No disease-specific therapy or trial identified. DOI: https://doi.org/10.1177/1120672119862505 (2020); https://doi.org/10.1097/ICO.0000000000003420 (2024) (weiss2024ic3dclassificationof pages 48-49, alafaleq2020multimodalimagingof pages 6-9) | No prevalence/incidence estimates specific to isolated PDCD; no validated gene; little natural-history data; no penetrance estimates; no biomarker, trial, or pathology-standardized management pathway. Distinction from cornea farinata and secondary/systemic causes remains imperfect. (weiss2024ic3dclassificationof pages 48-49, alafaleq2020multimodalimagingof pages 6-9, alafaleq2020multimodalimagingof pages 4-6) |
| Punctiform and polychromatic pre-Descemet corneal dystrophy (PPPCD); genetically supported distinct subtype; IC3D category 1 in 2024 | Autosomal dominant; PRDX3 is the leading causal gene. Recurrent heterozygous PRDX3 c.568G>C (p.Asp190His) identified in 4 of 5 reported families in the 2020 genetic study; PDZD8 c.872+10A>T segregated in 3 of 5 families but was not favored as the main cause. DOI: https://doi.org/10.1016/j.ajo.2019.11.024 (2020); https://doi.org/10.1097/ICO.0000000000003420 (2024) (barrio2020punctiformandpolychromatic pages 1-8, barrio2020punctiformandpolychromatic pages 17-21, barrio2020punctiformandpolychromatic pages 26-30, weiss2024ic3dclassificationof pages 11-12) | Posterior stromal/pre-Descemetic multicolored polychromatic punctiform opacities, usually bilateral; typically asymptomatic and without visual disturbance; cases reported from childhood to late adulthood, often nonprogressive or only mildly progressive. DOI: https://doi.org/10.1016/j.ajo.2019.11.024 (2020); https://doi.org/10.1097/ICO.0000000000003420 (2024) (barrio2020punctiformandpolychromatic pages 1-8, weiss2024ic3dclassificationof pages 48-49, barrio2020punctiformandpolychromatic pages 12-17) | Strongest evidence is the 2020 family-based study: 12 affected individuals from 3 previously unreported families within a larger set of 5 PPPCD families; segregation plus recurrence of PRDX3 p.Asp190His across families. Imaging showed hyperreflective posterior stromal/Descemet-level opacities; only measured biomechanical abnormality was increased corneal stiffness. DOI: https://doi.org/10.1016/j.ajo.2019.11.024 (2020) (barrio2020punctiformandpolychromatic pages 1-8, barrio2020punctiformandpolychromatic pages 17-21, barrio2020punctiformandpolychromatic pages 26-30) | High confidence for a gene-disease relationship relative to other PDCD forms; moderate confidence for mechanism. PRDX3 encodes a mitochondrial antioxidant peroxidase regulating mitochondrial reactive oxygen species, but direct human corneal molecular profiling remains sparse. DOI: https://doi.org/10.1016/j.ajo.2019.11.024 (2020); https://doi.org/10.1097/ICO.0000000000003420 (2024) (barrio2020punctiformandpolychromatic pages 17-21, weiss2024ic3dclassificationof pages 11-12) | Observation and follow-up are usual because visual function is largely preserved; genetic counseling is reasonable given autosomal-dominant inheritance. No targeted therapy or registered clinical trial found. DOI: https://doi.org/10.1016/j.ajo.2019.11.024 (2020); https://doi.org/10.1097/ICO.0000000000003420 (2024) (barrio2020punctiformandpolychromatic pages 1-8, weiss2024ic3dclassificationof pages 48-49) | Extremely small literature base (about 10 families before 2020); prevalence unknown; penetrance and expressivity incompletely quantified; possible locus heterogeneity remains unresolved; uncertain whether extra-corneal crystals in isolated reports indicate a broader systemic process in some families. (barrio2020punctiformandpolychromatic pages 1-8, weiss2024ic3dclassificationof pages 11-12) |
| STS/X-linked ichthyosis-associated pre-Descemet opacities; better viewed as syndromic/secondary pre-Descemet corneal changes rather than primary isolated dystrophy | X-linked recessive STS deficiency. Case report demonstrated complete deletion of all 10 STS exons and flanking sequence failure by PCR in a 34-year-old man with known X-linked ichthyosis. DOI: https://doi.org/10.1186/s12886-017-0423-5 (2017) (shi2017invivoconfocal pages 4-5, shi2017invivoconfocal pages 1-2, shi2017invivoconfocal pages 2-4) | Bilateral tiny pleomorphic gray-brownish posterior stromal opacities anterior to Descemet membrane, with preserved corrected visual acuity (20/20 both eyes after refraction in the reported case); skin dryness/scaling from infancy; stable over 1 year in the published case. DOI: https://doi.org/10.1186/s12886-017-0423-5 (2017) (shi2017invivoconfocal pages 1-2, shi2017invivoconfocal pages 2-4) | Single detailed human case report with slit-lamp, IVCM, dermatologic exam, and molecular confirmation of STS deletion. IVCM showed enlarged activated posterior stromal keratocytes containing regularly distributed hyperreflective particles and additional anterior stromal particles; endothelial cell density remained normal. DOI: https://doi.org/10.1186/s12886-017-0423-5 (2017) (shi2017invivoconfocal pages 4-5, shi2017invivoconfocal pages 1-2, shi2017invivoconfocal pages 2-4) | Moderate for a secondary metabolic/deposition mechanism: authors proposed STS deficiency elevates cholesterol sulfate, causing lysosomal dysfunction and lipid accumulation in keratocytes; however this is based mainly on clinicopathologic inference and one genetically confirmed case. DOI: https://doi.org/10.1186/s12886-017-0423-5 (2017) (shi2017invivoconfocal pages 4-5, shi2017invivoconfocal pages 2-4) | Management centers on recognition of the ocular finding within X-linked ichthyosis, observation, and systemic/genetic counseling; no cornea-specific intervention was needed in the reported case. DOI: https://doi.org/10.1186/s12886-017-0423-5 (2017) (shi2017invivoconfocal pages 4-5, shi2017invivoconfocal pages 1-2) | Evidence limited to isolated cases; unclear prevalence among STS-deficient patients; natural history and treatment thresholds unknown; uncertain whether this should be classified with primary corneal dystrophies or as a manifestation of systemic disease. (weiss2024ic3dclassificationof pages 48-49, shi2017invivoconfocal pages 4-5, shi2017invivoconfocal pages 2-4) |
Table: This table contrasts the main evidence-supported forms of pre-Descemet corneal disease: poorly defined isolated PDCD, PRDX3-associated PPPCD, and STS/X-linked ichthyosis-associated pre-Descemet opacities. It summarizes what is established, what is inferred, and where major evidence gaps remain.
PDCD denotes bilateral, generally noninflammatory deposits in the deep corneal stroma immediately anterior to Descemet membrane. The classic appearance is numerous fine, gray, polymorphic opacities; PPPCD has larger punctiform opacities with a distinctive multicolored or polychromatic appearance. Vision is usually preserved. IC3D describes isolated PDCD as neither a well-defined hereditary dystrophy nor an unequivocal degeneration, whereas PRDX3-associated PPPCD now meets category-1 criteria. (weiss2024ic3dclassificationof pages 48-49, weiss2024ic3dclassificationof pages 11-12)
Names and synonyms: pre-Descemet corneal dystrophy; pre-Descemet’s membrane corneal dystrophy; deep filiform dystrophy; deep punctiform dystrophy; cornea farinata (historically overlapping, but now better regarded as a degeneration); punctiform and polychromatic pre-Descemet corneal dystrophy; posterior polychromatic corneal dystrophy. (weiss2024ic3dclassificationof pages 48-49)
Identifiers: no confidently validated disease-specific OMIM, Orphanet, MONDO, MeSH, ICD-10, or ICD-11 identifier was established in the retrieved authoritative literature. A knowledge base should therefore retain the label as an IC3D entity and avoid assigning an unverified MONDO ID. Generic coding may fall under corneal dystrophy or corneal opacity, but that is not disease-specific.
The evidence is aggregated disease-level literature—IC3D expert classification, family studies, and small case series—not individual EHR data. The core sources are IC3D Edition 3, published February 2024 (DOI), and the family/genetic study published April 2020 (DOI). PMIDs were not exposed in the retrieved records and should be verified directly in PubMed before database deposition. (barrio2020punctiformandpolychromatic pages 1-8, weiss2024ic3dclassificationof pages 48-49)
Family history is the principal recognized risk indicator for PPPCD. Cases in the genetic series ranged from 8 to 79 years, showing that detectable disease may span much of life. Geographic clustering among Spanish/Spanish-ancestry and Brazilian families was observed, but the sample is too small to establish a founder effect or population-specific risk. (barrio2020punctiformandpolychromatic pages 17-21, barrio2020punctiformandpolychromatic pages 12-17)
No reproducible toxin, diet, smoking, alcohol, occupational, infectious, or lifestyle cause has been demonstrated. No protective allele, diet, medication, or behavioral intervention is known. Age may affect detectability—classic PDCD is usually recognized after age 30—but PPPCD has been seen by age 3, so age is not a causal exposure. No validated gene–environment interaction exists. (weiss2024ic3dclassificationof pages 48-49)
A report proposing vaccine/surgical stimulation in a person with an ARSG variant is insufficient to establish causation and should not be treated as a recognized PDCD risk factor.
| Phenotype | Type and characteristics | Suggested HPO annotation |
|---|---|---|
| Deep stromal corneal opacities | Objective sign; bilateral fine gray/polymorphic deposits immediately anterior to Descemet membrane, usually extending broadly across the cornea | Corneal opacity, HP:0007957; bilateral qualifier; posterior/deep stromal location as free-text qualifier |
| Polychromatic punctiform deposits | PPPCD-defining sign; multicolored punctate posterior stromal opacities | Corneal opacity (HP:0007957), punctate/polychromatic morphology qualifier |
| Preserved visual acuity/asymptomatic state | Most common clinical state; one IC3D-cited patient reported glare | “Asymptomatic” should be represented as absence of symptoms rather than a positive HPO phenotype |
| Glare | Rare symptom; frequency cannot be estimated | Glare/photophobia concept if locally supported; do not infer photophobia from glare alone |
| Increased corneal stiffness | Quantitative biomechanical abnormality in the 2020 family study; clinical significance uncertain | No validated disease-specific HPO mapping identified |
| X-linked ichthyosis features | Syndromic STS cases may have generalized dry, coarse, scaling skin | Annotate under X-linked ichthyosis, not primary PPPCD |
PPPCD is typically mild, bilateral, asymptomatic, and nonprogressive or only mildly progressive. Other PDCD/cornea-farinata-like forms may progress slowly. Onset is commonly recognized in adulthood, but childhood PPPCD is documented. No reliable phenotype frequencies beyond “usually” or “typically” are available because published cohorts are extremely small. (weiss2024ic3dclassificationof pages 48-49, barrio2020punctiformandpolychromatic pages 1-8)
No validated EQ-5D, SF-36, PROMIS, or vision-related quality-of-life study exists. Since corrected acuity is generally normal, everyday functional impact is expected to be minimal, although glare or diagnostic anxiety may matter in individual patients. This is clinical inference rather than measured evidence.
PRDX3 encodes mitochondrial peroxiredoxin-3, an antioxidant peroxidase that regulates mitochondrial reactive oxygen species. The recurrent p.Asp190His substitution was novel in the 2020 study, predicted damaging, and had a CADD score of 31. The retrieved record did not provide a defensible ClinVar classification or current gnomAD allele frequency; therefore “pathogenic” should be used only in the disease-association sense supported by segregation and IC3D category 1, not asserted as a current ClinVar/ACMG record without database verification. (barrio2020punctiformandpolychromatic pages 17-21, barrio2020punctiformandpolychromatic pages 12-17)
The variant is germline, heterozygous, and missense. A dominant-negative versus gain-of-function versus haploinsufficiency mechanism has not been experimentally established. No modifier gene, protective allele, chromosomal rearrangement, somatic mutation, methylation signature, histone change, or other disease-specific epigenetic mechanism is known. The PDZD8 intronic allele remains a candidate rather than a confirmed independent cause. (barrio2020punctiformandpolychromatic pages 1-8, barrio2020punctiformandpolychromatic pages 17-21)
For STS-associated disease, the reported lesion was a germline X-chromosomal deletion encompassing all ten exons and flanking sequence. In the reported male it produced the expected X-linked hemizygous deficiency. (shi2017invivoconfocal pages 1-2, shi2017invivoconfocal pages 2-4)
PDCD/PPPCD is not infectious and is not linked to pollution, radiation, smoking, diet, exercise, alcohol, or occupational exposure. Important acquired mimics include crystalline keratopathy and occupational corneal deposits such as argyrosis; these are differential diagnoses, not proven triggers of inherited PPPCD. No environmental prevention strategy is supported.
A biologically plausible chain is:
germline PRDX3 p.Asp190His → altered mitochondrial peroxide handling in corneal keratocytes → oxidative/proteostatic stress → intracellular and extracellular deposit formation, greatest in posterior stroma → punctiform polychromatic slit-lamp opacities.
The first step—gene association—is strong; the downstream oxidative/deposition chain is plausible but not directly demonstrated by corneal transcriptomics, proteomics, metabolomics, or functional editing studies. (barrio2020punctiformandpolychromatic pages 17-21, weiss2024ic3dclassificationof pages 11-12)
IVCM and ultrastructure support a keratocyte-centered degenerative process. Enlarged posterior keratocytes contain membrane-bound vacuoles with electron-dense, lipofuscin-like material; extracellular particles occur throughout the stroma, with maximal damage anterior to Descemet membrane. Epithelium and endothelium are largely spared. (alafaleq2020multimodalimagingof pages 1-2, alafaleq2020multimodalimagingof pages 6-9, alafaleq2020multimodalimagingof pages 4-6)
The 2020 multimodal study’s abstract concluded that findings were “in favor of a degenerative process affecting corneal keratocytes with no epithelial or endothelial involvement.” It also reported that imaging “reveals that the disorder affects the whole stroma.” (DOI, September 2020). (alafaleq2020multimodalimagingof pages 1-2)
A proposed chain is:
STS deletion → steroid sulfatase deficiency → cholesterol-sulfate accumulation → lysosomal dysfunction/lipid retention in keratocytes → intracellular hyperreflective particles and posterior stromal opacity.
This mechanism is supported by biochemical plausibility and one genetically confirmed clinical case, not by direct human corneal metabolomics. (shi2017invivoconfocal pages 4-5, shi2017invivoconfocal pages 2-4)
Suggested ontology terms: corneal stromal keratocyte (CL term should be curator-verified); corneal stroma and posterior corneal stroma (UBERON); mitochondrion (GO:0005739); lysosome (GO:0005764); response to oxidative stress (GO:0006979); reactive oxygen species metabolic process (GO:0072593); lipid storage/lysosomal organization as provisional biological-process annotations. No immune, inflammatory, ischemic, necrotic, or fibrotic mechanism is established.
No disease-specific bulk/single-cell RNA-seq, spatial transcriptomics, proteomics, metabolomics, lipidomics, multi-omics integration, CRISPR screen, or organoid study was found.
The disease is restricted predominantly to the cornea, especially the deep/posterior stroma immediately anterior to Descemet membrane. Imaging shows lesser deposits and activated keratocytes across anterior and middle stroma as well. Corneal epithelial thickness, Descemet membrane, endothelium, and central corneal thickness are generally normal. (alafaleq2020multimodalimagingof pages 2-4, alafaleq2020multimodalimagingof pages 6-9)
The target cell is the corneal stromal keratocyte. Relevant compartments include mitochondria for PRDX3 biology and lysosomal/vacuolar compartments for lipofuscin-like storage. Disease is typically bilateral and broadly distributed, often limbus-to-limbus, although one STS case retained a 2–3-mm clear perilimbal zone. (shi2017invivoconfocal pages 1-2, alafaleq2020multimodalimagingof pages 2-4)
Suggested anatomy annotations are cornea (UBERON:0000964), corneal stroma, Descemet membrane as an adjacency landmark, and bilateral eye involvement. No established secondary-organ involvement exists in isolated PPPCD; skin involvement belongs to syndromic STS deficiency. IC3D notes a report of crystals under the lens capsule, leaving open whether rare PPPCD may occasionally be systemic. (weiss2024ic3dclassificationof pages 11-12)
Classic PDCD is most often recognized after age 30 and develops insidiously. PPPCD can be detected in early childhood and has been documented across ages 3–79. In the 2020 family cohort, affected individuals were 8–79 years old, with mean age 42.9 years. (weiss2024ic3dclassificationof pages 48-49, barrio2020punctiformandpolychromatic pages 12-17)
There is no validated staging system. A practical descriptive sequence is: subclinical deposits detectable by IVCM/OCT; visible punctiform posterior stromal deposits; stable or mildly increasing deposit burden. End-stage corneal decompensation is not characteristic. One STS-associated case remained unchanged at one year. (weiss2024ic3dclassificationof pages 48-49, shi2017invivoconfocal pages 1-2)
The condition is chronic/lifelong once present. Spontaneous remission, relapsing-remitting behavior, critical treatment windows, and treatment-induced remission have not been documented.
PPPCD follows autosomal-dominant inheritance. Penetrance appears substantial in reported pedigrees but has not been quantified; age-dependent ascertainment is possible. Expressivity is variable in deposit burden, age of recognition, and occasional glare, but visual function is usually preserved. Anticipation, germline mosaicism, consanguinity effects, carrier frequency, and sex bias are unknown. (barrio2020punctiformandpolychromatic pages 1-8, weiss2024ic3dclassificationof pages 48-49)
Only about ten families had been reported before the 2020 study. That study evaluated 21 relatives from three additional families, including 12 affected individuals. These counts demonstrate extreme rarity but cannot yield prevalence or incidence. No population-based rate per 100,000 is available. (barrio2020punctiformandpolychromatic pages 1-8)
Spanish/Spanish-ancestry and Brazilian clustering is reported, but founder status has not been established. Both sexes can be affected in autosomal-dominant PPPCD. The male predominance in one four-patient sporadic imaging series cannot establish a sex ratio. (barrio2020punctiformandpolychromatic pages 17-21, alafaleq2020multimodalimagingof pages 1-2)
In the STS-associated case, corrected acuity reached 20/20 in both eyes and endothelial densities were 3,347 and 3,095 cells/mm². IVCM localized 2.0–3.4-µm particles within posterior keratocytes at 321–494 µm depth. (shi2017invivoconfocal pages 1-2)
For a convincing polychromatic familial phenotype, sequence PRDX3, preferably through an inherited corneal-dystrophy panel with deletion/duplication analysis and segregation testing. Targeted testing for c.568G>C is efficient in a known family. WES/WGS is appropriate when PRDX3 testing is negative, the phenotype is atypical, or syndromic findings suggest another diagnosis. In males with ichthyosis, test STS by copy-number analysis plus sequencing. CMA may detect a larger Xp22.3 deletion. Karyotyping, FISH, mitochondrial DNA testing, and repeat-expansion assays have no routine role unless another clinical indication exists. (barrio2020punctiformandpolychromatic pages 1-8, shi2017invivoconfocal pages 2-4)
Important alternatives are cornea farinata; fleck corneal dystrophy; central cloudy dystrophy of François; posterior amorphous corneal dystrophy; Fuchs endothelial corneal dystrophy/cornea guttata; posterior polymorphous corneal dystrophy; crystalline infectious keratopathy; Schnyder corneal dystrophy; cystinosis; drug/toxin or silver deposits; and pre-Descemet opacities secondary to X-linked ichthyosis. Normal endothelium, lack of edema/inflammation, posterior stromal keratocyte localization, polychromasia, and PRDX3 segregation favor PPPCD. (alafaleq2020multimodalimagingof pages 6-9)
There are no universally validated numerical diagnostic criteria. Asymptomatic relatives in a PRDX3-positive family can undergo cascade slit-lamp examination and targeted testing. Population or newborn screening is not indicated.
Prognosis is excellent. Most patients remain asymptomatic with preserved corrected acuity, and the disease does not affect survival or life expectancy. No disease-specific mortality, five- or ten-year survival statistic, disability rate, or quality-of-life score exists. (weiss2024ic3dclassificationof pages 48-49, barrio2020punctiformandpolychromatic pages 1-8)
When reduced vision is present, published imaging series attributed it to other conditions such as amblyopia, cataract, or retinal pigment epitheliopathy rather than PDCD. Corneal edema, endothelial failure, recurrent erosions, ulceration, and blindness are not characteristic complications. (alafaleq2020multimodalimagingof pages 6-9)
No validated prognostic biomarker exists. Deposit burden, symptoms, acuity, and serial OCT/IVCM are reasonable monitoring measures, but their predictive value is unproven.
Standard care is observation and periodic ophthalmic review. Refractive correction treats coincidental ametropia; glare can be managed symptomatically. Genetic counseling is appropriate for PRDX3-positive families and STS-associated disease. A 2025 case report likewise recommended observation/follow-up and noninvasive imaging. (nicoli2025distrofiacornealpredescemética pages 3-5)
No drug, antioxidant, lysosomal therapy, gene therapy, RNA therapy, cell therapy, PTK, keratoplasty, or other surgery has demonstrated disease-specific benefit. Because deposits are deep and visual acuity is generally preserved, PTK is anatomically inappropriate in routine PPPCD. Corneal transplantation would be considered only for exceptional, proven visually significant stromal opacity after exclusion of other causes; no response rate or recurrence estimate exists.
No relevant interventional ClinicalTrials.gov study or disease-specific NCT identifier was found. Generic patents and experimental gene-editing approaches for other corneal dystrophies do not constitute evidence for PDCD treatment. Suggested NCIT concepts are Observation, Genetic Counseling, Visual Acuity Test, Optical Coherence Tomography, and, only if exceptionally indicated, Corneal Transplantation; exact NCIT codes should be terminology-service verified.
Primary prevention is unavailable for a germline disorder. No vaccine, prophylactic drug, diet, or exposure avoidance prevents PPPCD. Secondary prevention consists of cascade examination/testing in affected families, allowing early diagnosis and avoidance of unnecessary treatment. Tertiary prevention consists of routine monitoring and treatment of unrelated visual problems.
Genetic counseling should explain autosomal-dominant transmission—nominally a 50% variant-transmission probability from a heterozygous parent—while emphasizing that penetrance and severity are not adequately quantified. Prenatal or preimplantation testing is technically possible once a familial pathogenic variant is confirmed but is rarely proportionate for a usually asymptomatic, non–vision-threatening condition. STS families require X-linked counseling. No population screening or public-health intervention is justified.
No genetically confirmed natural PRDX3-associated PDCD has been established in another species. A 2022 canine report described bilateral, noninflammatory posterior stromal opacities with hyperreflective deposits within keratocytes and increasing numbers of enlarged deposit-containing keratocytes toward the posterior stroma. The authors judged this “reminiscent of pre-Descemet corneal dystrophy” in humans, but no orthologous mutation was demonstrated; it is therefore a comparative phenocopy, not a validated natural model. Relevant taxonomy is domestic dog, Canis lupus familiaris (NCBI Taxon 9615). Breed/VBO assignment was not established in the retrieved evidence.
There is no zoonotic or transmissible potential.
No validated PRDX3 knock-in mouse, rat, zebrafish, invertebrate, organoid, iPSC, or corneal-cell model has been shown to reproduce human PPPCD deposits. Likewise, no STS-deficient model has been validated specifically for the corneal phenotype. The canine observation may help define comparative imaging features but cannot establish causality or therapeutic response.
Priority models would include: (1) a heterozygous PRDX3 p.Asp190His knock-in animal; (2) patient-derived keratocytes or iPSC-derived corneal stromal cells; and (3) engineered corneal stromal organoids assessing mitochondrial peroxide handling, keratocyte vacuoles, lipofuscin/lipid deposition, transparency, and biomechanics. These are research recommendations, not currently validated resources.
The key recent advance is the February 2024 IC3D reclassification: PRDX3-associated PPPCD is now category 1, while isolated nonpolychromatic PDCD remains category 4. IC3D’s abstract states: “Pre-Descemet corneal dystrophies include category 1, autosomal dominant, punctiform and polychromatic pre-Descemet corneal dystrophy (PPPCD) (PRDX3 mutations, chromosome 10)” and notes that it is “typically asymptomatic.” (DOI, February 2024). (weiss2024ic3dclassificationof pages 48-49)
The foundational genetic evidence remains the April 2020 family study: 12 affected people in three newly reported families, recurrence of PRDX3 p.Asp190His in four of five families evaluated across the study, and significantly increased corneal stiffness as the principal measured biomechanical abnormality. Its main limitations are small sample size, concentration in a few ancestries, prediction rather than direct functional proof, and unresolved locus heterogeneity. (barrio2020punctiformandpolychromatic pages 1-8, barrio2020punctiformandpolychromatic pages 17-21)
Overall, evidence is moderate-to-strong for PRDX3 as the cause of PPPCD, moderate for a keratocyte deposition/degeneration mechanism, and very low for epidemiology, quantified natural history, molecular profiling, or treatment efficacy. The most important database-curation safeguard is to keep PRDX3-associated PPPCD, category-4 isolated PDCD/cornea farinata, and STS-associated syndromic deposits as related but distinct assertions.
References
(weiss2024ic3dclassificationof pages 48-49): Jayne S. Weiss, Christopher J. Rapuano, Berthold Seitz, Massimo Busin, Tero T. Kivelä, Nacim Bouheraoua, Cecilie Bredrup, Ken K. Nischal, Harshvardhan Chawla, Vincent Borderie, Kenneth R. Kenyon, Eung Kweon Kim, Hans Ulrik Møller, Francis L. Munier, Tim Berger, and Walter Lisch. Ic3d classification of corneal dystrophies—edition 3. Cornea, 43:466-527, Feb 2024. URL: https://doi.org/10.1097/ico.0000000000003420, doi:10.1097/ico.0000000000003420. This article has 119 citations and is from a peer-reviewed journal.
(weiss2024ic3dclassificationof pages 11-12): Jayne S. Weiss, Christopher J. Rapuano, Berthold Seitz, Massimo Busin, Tero T. Kivelä, Nacim Bouheraoua, Cecilie Bredrup, Ken K. Nischal, Harshvardhan Chawla, Vincent Borderie, Kenneth R. Kenyon, Eung Kweon Kim, Hans Ulrik Møller, Francis L. Munier, Tim Berger, and Walter Lisch. Ic3d classification of corneal dystrophies—edition 3. Cornea, 43:466-527, Feb 2024. URL: https://doi.org/10.1097/ico.0000000000003420, doi:10.1097/ico.0000000000003420. This article has 119 citations and is from a peer-reviewed journal.
(alafaleq2020multimodalimagingof pages 1-2): Munirah Alafaleq, Cristina Georgeon, Kate Grieve, and Vincent M Borderie. Multimodal imaging of pre-descemet corneal dystrophy. European Journal of Ophthalmology, 30:908-916, Sep 2020. URL: https://doi.org/10.1177/1120672119862505, doi:10.1177/1120672119862505. This article has 9 citations and is from a peer-reviewed journal.
(alafaleq2020multimodalimagingof pages 4-6): Munirah Alafaleq, Cristina Georgeon, Kate Grieve, and Vincent M Borderie. Multimodal imaging of pre-descemet corneal dystrophy. European Journal of Ophthalmology, 30:908-916, Sep 2020. URL: https://doi.org/10.1177/1120672119862505, doi:10.1177/1120672119862505. This article has 9 citations and is from a peer-reviewed journal.
(alafaleq2020multimodalimagingof pages 6-9): Munirah Alafaleq, Cristina Georgeon, Kate Grieve, and Vincent M Borderie. Multimodal imaging of pre-descemet corneal dystrophy. European Journal of Ophthalmology, 30:908-916, Sep 2020. URL: https://doi.org/10.1177/1120672119862505, doi:10.1177/1120672119862505. This article has 9 citations and is from a peer-reviewed journal.
(alafaleq2020multimodalimagingof pages 2-4): Munirah Alafaleq, Cristina Georgeon, Kate Grieve, and Vincent M Borderie. Multimodal imaging of pre-descemet corneal dystrophy. European Journal of Ophthalmology, 30:908-916, Sep 2020. URL: https://doi.org/10.1177/1120672119862505, doi:10.1177/1120672119862505. This article has 9 citations and is from a peer-reviewed journal.
(barrio2020punctiformandpolychromatic pages 1-8): Jorge L. Alió del Barrio, Doug D. Chung, Olena Al-Shymali, Alice Barrington, Kavya Jatavallabhula, Vinay S. Swamy, Pilar Yébana, Maria Angélica Henríquez-Recine, Ana Boto-de-los-Bueis, Jorge L. Alió, and Anthony J. Aldave. Punctiform and polychromatic pre-descemet corneal dystrophy: clinical evaluation and identification of the genetic basis. American Journal of Ophthalmology, 212:88-97, Apr 2020. URL: https://doi.org/10.1016/j.ajo.2019.11.024, doi:10.1016/j.ajo.2019.11.024. This article has 12 citations and is from a domain leading peer-reviewed journal.
(barrio2020punctiformandpolychromatic pages 17-21): Jorge L. Alió del Barrio, Doug D. Chung, Olena Al-Shymali, Alice Barrington, Kavya Jatavallabhula, Vinay S. Swamy, Pilar Yébana, Maria Angélica Henríquez-Recine, Ana Boto-de-los-Bueis, Jorge L. Alió, and Anthony J. Aldave. Punctiform and polychromatic pre-descemet corneal dystrophy: clinical evaluation and identification of the genetic basis. American Journal of Ophthalmology, 212:88-97, Apr 2020. URL: https://doi.org/10.1016/j.ajo.2019.11.024, doi:10.1016/j.ajo.2019.11.024. This article has 12 citations and is from a domain leading peer-reviewed journal.
(barrio2020punctiformandpolychromatic pages 26-30): Jorge L. Alió del Barrio, Doug D. Chung, Olena Al-Shymali, Alice Barrington, Kavya Jatavallabhula, Vinay S. Swamy, Pilar Yébana, Maria Angélica Henríquez-Recine, Ana Boto-de-los-Bueis, Jorge L. Alió, and Anthony J. Aldave. Punctiform and polychromatic pre-descemet corneal dystrophy: clinical evaluation and identification of the genetic basis. American Journal of Ophthalmology, 212:88-97, Apr 2020. URL: https://doi.org/10.1016/j.ajo.2019.11.024, doi:10.1016/j.ajo.2019.11.024. This article has 12 citations and is from a domain leading peer-reviewed journal.
(barrio2020punctiformandpolychromatic pages 12-17): Jorge L. Alió del Barrio, Doug D. Chung, Olena Al-Shymali, Alice Barrington, Kavya Jatavallabhula, Vinay S. Swamy, Pilar Yébana, Maria Angélica Henríquez-Recine, Ana Boto-de-los-Bueis, Jorge L. Alió, and Anthony J. Aldave. Punctiform and polychromatic pre-descemet corneal dystrophy: clinical evaluation and identification of the genetic basis. American Journal of Ophthalmology, 212:88-97, Apr 2020. URL: https://doi.org/10.1016/j.ajo.2019.11.024, doi:10.1016/j.ajo.2019.11.024. This article has 12 citations and is from a domain leading peer-reviewed journal.
(shi2017invivoconfocal pages 4-5): Hui Shi, Xiao-feng Qi, Tao-tao Liu, Qian Hao, Xiao-hong Li, Ling-ling Liang, Yi-miao Wang, and Zhi-hua Cui. In vivo confocal microscopy of pre-descemet corneal dystrophy associated with x-linked ichthyosis: a case report. BMC Ophthalmology, Mar 2017. URL: https://doi.org/10.1186/s12886-017-0423-5, doi:10.1186/s12886-017-0423-5. This article has 18 citations and is from a peer-reviewed journal.
(shi2017invivoconfocal pages 1-2): Hui Shi, Xiao-feng Qi, Tao-tao Liu, Qian Hao, Xiao-hong Li, Ling-ling Liang, Yi-miao Wang, and Zhi-hua Cui. In vivo confocal microscopy of pre-descemet corneal dystrophy associated with x-linked ichthyosis: a case report. BMC Ophthalmology, Mar 2017. URL: https://doi.org/10.1186/s12886-017-0423-5, doi:10.1186/s12886-017-0423-5. This article has 18 citations and is from a peer-reviewed journal.
(shi2017invivoconfocal pages 2-4): Hui Shi, Xiao-feng Qi, Tao-tao Liu, Qian Hao, Xiao-hong Li, Ling-ling Liang, Yi-miao Wang, and Zhi-hua Cui. In vivo confocal microscopy of pre-descemet corneal dystrophy associated with x-linked ichthyosis: a case report. BMC Ophthalmology, Mar 2017. URL: https://doi.org/10.1186/s12886-017-0423-5, doi:10.1186/s12886-017-0423-5. This article has 18 citations and is from a peer-reviewed journal.
(nicoli2025distrofiacornealpredescemética pages 3-5): CM Nicoli and ES López. Distrofia corneal pre-descemética. Unknown journal, 2025.
Checked with linkml-reference-validator 0.2.1.
| Outcome | Count |
|---|---|
| References checked | 5 |
| Resolved | 5 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| Quoted claims checked | 2 |
| Quoted claims found in source | 2 |
| Quoted claims not found in source | 0 |
| References weighed for topical relevance | 5 |
| On topic | 1 |
| Off topic | 0 |
All extracted references resolved successfully.